Andrew S. Moore

Oncology Service, Children's Health Queensland Hospital and Health Service

Affiliated withChildren's Health Queensland Hospital and Health Service The University of Queensland

Research Area

Cancer Research

Biography

Andrew S. Moore has not added Biography.
If you are Andrew S. Moore and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2021

Other Publications

Article	Year
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia. International journal of nanomedicine\| PubMed ID: 24232122	2013
Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia. Leukemia research\| PubMed ID: 25659731	2015
The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry. Pediatric blood & cancer\| PubMed ID: 25855531	2015
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell\| PubMed ID: 26919435	2016
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nature communications\| PubMed ID: 27048880	2016
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? Cancer chemotherapy and pharmacology\| PubMed ID: 28444427	2017
Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? Cancer chemotherapy and pharmacology\| PubMed ID: 28597037	2017
Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer cell\| PubMed ID: 28609654	2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. Cancer letters\| PubMed ID: 28866095	2017
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica\| PubMed ID: 28935844	2017
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer cell\| PubMed ID: 28966033	2017
Targeted Next-Generation Sequencing for Detecting Gene Fusions in Leukemia. Molecular cancer research : MCR\| PubMed ID: 29133595	2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours. Oncotarget\| PubMed ID: 29340109	2017
The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion. Scientific reports\| PubMed ID: 29348602	2018
Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Challenges and Future Directions. The Journal of molecular diagnostics : JMD\| PubMed ID: 29689379	2018
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. Nature medicine\| PubMed ID: 29967352	2018
Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study. The Lancet. Child & adolescent health\| PubMed ID: 30169253	2018
Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study. Pediatric blood & cancer\| PubMed ID: 30183136	2018
Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry. Pediatric blood & cancer\| PubMed ID: 30803139	2019